JP2024523488A5 - - Google Patents
Info
- Publication number
- JP2024523488A5 JP2024523488A5 JP2023579045A JP2023579045A JP2024523488A5 JP 2024523488 A5 JP2024523488 A5 JP 2024523488A5 JP 2023579045 A JP2023579045 A JP 2023579045A JP 2023579045 A JP2023579045 A JP 2023579045A JP 2024523488 A5 JP2024523488 A5 JP 2024523488A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- cycloalkyl
- alkyl
- compound
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163215054P | 2021-06-25 | 2021-06-25 | |
| US63/215,054 | 2021-06-25 | ||
| PCT/EP2022/067376 WO2022269049A1 (en) | 2021-06-25 | 2022-06-24 | Sulfonamide orexin receptor agonists and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523488A JP2024523488A (ja) | 2024-06-28 |
| JP2024523488A5 true JP2024523488A5 (enExample) | 2025-06-24 |
Family
ID=82458613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023579045A Pending JP2024523488A (ja) | 2021-06-25 | 2022-06-24 | スルホンアミドオレキシン受容体アゴニスト及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240360081A1 (enExample) |
| EP (1) | EP4359387A1 (enExample) |
| JP (1) | JP2024523488A (enExample) |
| KR (1) | KR20240026483A (enExample) |
| CN (1) | CN117769542A (enExample) |
| AU (1) | AU2022299418A1 (enExample) |
| CA (1) | CA3224033A1 (enExample) |
| IL (1) | IL309108A (enExample) |
| MX (1) | MX2023015074A (enExample) |
| WO (1) | WO2022269049A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11760747B2 (en) | 2020-12-21 | 2023-09-19 | Alkermes, Inc. | Substituted piperidino compounds and related methods of treatment |
| US12006330B2 (en) | 2020-12-21 | 2024-06-11 | Alkermes, Inc. | Substituted macrocyclic compounds and related methods of treatment |
| JP7833486B2 (ja) | 2021-05-26 | 2026-03-19 | アルカーメス，インコーポレイテッド | 置換されるカルバメート大環状化合物および関連のある治療方法 |
| CN122374291A (zh) | 2023-12-12 | 2026-07-10 | 爱杜西亚药品有限公司 | 作为食欲素受体调节剂的芳基砜及砜酮衍生物 |
| WO2025132542A1 (en) | 2023-12-19 | 2025-06-26 | Idorsia Pharmaceuticals Ltd | Macrocyclic orexin agonists |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5374641A (en) * | 1991-02-25 | 1994-12-20 | Terumo Kabushiki Kaisha | N-(3-pyridylalkyl)sulfonamide compounds which have useful pharmaceutical activity |
| EP1741709A1 (en) * | 2005-06-28 | 2007-01-10 | Sanofi-Aventis Deutschland GmbH | Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
| SG11201806429PA (en) * | 2016-02-04 | 2018-08-30 | Takeda Pharmaceuticals Co | Substituted piperidine compound and use thereof |
| EP3621962A4 (en) * | 2017-05-10 | 2020-12-09 | Forge Therapeutics, Inc. | ANTIBACTERIAL COMPOUNDS |
| WO2019191327A1 (en) * | 2018-03-27 | 2019-10-03 | Board Of Regents, The University Of Texas System | Ox2r compounds |
| WO2020167701A1 (en) * | 2019-02-13 | 2020-08-20 | Merck Sharp & Dohme Corp. | Pyrrolidine orexin receptor agonists |
| US11098029B2 (en) * | 2019-02-13 | 2021-08-24 | Merck Sharp & Dohme Corp. | 5-alkyl pyrrolidine orexin receptor agonists |
-
2022
- 2022-06-24 EP EP22738602.6A patent/EP4359387A1/en active Pending
- 2022-06-24 IL IL309108A patent/IL309108A/en unknown
- 2022-06-24 MX MX2023015074A patent/MX2023015074A/es unknown
- 2022-06-24 WO PCT/EP2022/067376 patent/WO2022269049A1/en not_active Ceased
- 2022-06-24 JP JP2023579045A patent/JP2024523488A/ja active Pending
- 2022-06-24 CN CN202280044807.8A patent/CN117769542A/zh active Pending
- 2022-06-24 AU AU2022299418A patent/AU2022299418A1/en active Pending
- 2022-06-24 KR KR1020247000316A patent/KR20240026483A/ko active Pending
- 2022-06-24 US US18/571,860 patent/US20240360081A1/en active Pending
- 2022-06-24 CA CA3224033A patent/CA3224033A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021169499A5 (enExample) | ||
| JP2023542541A5 (enExample) | ||
| RU2005117789A (ru) | Производные 4,5-диарилтиазола в качестве лигандов св-1 | |
| CN109803967A (zh) | 二氢嘧啶类化合物及其制备方法和用途 | |
| JP2024516033A5 (enExample) | ||
| JP2021514001A5 (enExample) | ||
| JP2011524422A5 (enExample) | ||
| JP2012522056A5 (enExample) | ||
| JP2021535134A5 (enExample) | ||
| JP2007519695A5 (enExample) | ||
| JP2020521767A5 (enExample) | ||
| JP2013538802A5 (enExample) | ||
| NO20072833L (no) | Bi- og tricykliske substituterte fenylmetanoner som glycinetransportor I-(Glyt-1)-inhibitorer for behandling av Alzheimers sykdom | |
| JP2013538801A5 (enExample) | ||
| JP2011506566A5 (enExample) | ||
| JP2022511477A5 (enExample) | ||
| JP2023535815A5 (enExample) | ||
| JP2005539045A5 (enExample) | ||
| JP2021530560A5 (enExample) | ||
| JP2016534984A5 (enExample) | ||
| JP2023553428A5 (enExample) | ||
| JP2022533939A5 (enExample) | ||
| RU2016117052A (ru) | Соединения для аффинной хроматографии и для продления времени полужизни терапевтического средства | |
| JP2020111571A5 (enExample) | ||
| JP2021533206A5 (enExample) |